Endurant Capital Management LP Insulet Corp Transaction History

Endurant Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$127.77 - $221.42 $499,069 - $864,866	3,906 New	3,906 $847,000
Q1 2022 May 16, 2022	SELL	$194.8 - $275.7 $1.25 Million - $1.76 Million	-6,394 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$255.32 - $318.29 $1.63 Million - $2.04 Million	6,394 New	6,394 $1.7 Million
Q3 2020 Nov 16, 2020	SELL	$192.55 - $236.59 $474,635 - $583,194	-2,465 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$159.17 - $224.73 $392,354 - $553,959	2,465 New	2,465 $479,000
Q1 2019 May 15, 2019	SELL	$72.44 - $101.87 $2.95 Million - $4.15 Million	-40,727 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$73.27 - $105.19 $2.98 Million - $4.28 Million	40,727 New	40,727 $3.23 Million

730

63.2M

630K

854K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.8B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.